@prefix nkg: . @prefix nt: . @prefix orcid: . @prefix bl: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { a bl:Disease . sub:association rdf:object ; rdf:predicate bl:treats; rdf:subject ; a rdf:Statement; rdfs:label "The purpose of this review is to summarize the current evidence of the off-label use of intravenous (IV) olanzapine and discuss its risks versus benefits for the management of agitation."; bl:has_population_context sub:context; bl:provided_by ; bl:publications ; bl:relation nkg:OffLabelIndication . sub:context a bl:Cohort; rdfs:label "Adults" . a bl:Drug . } sub:provenance { sub:assertion prov:generatedAtTime "2021-08-24T19:04:46.392178"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"; npx:hasSignature "SlaR0TqX8SrVotaTJDVKXuIMhGoIN6385wzSIZLVgNOvjd/t1nr5G47c6E702scuBtd5uoGX//W0Y90AaV/PdF5fMr2x7u/zNfH9mh77zWHiVxHo+EqBTy/uWP7bSYpxpVtCFZLSfnmWhHyc6cisH4BX4Zy1+Nnxufer+Jdg6kA="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-08-24T19:04:46.392178"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-7641-6446; nt:wasCreatedFromTemplate . }